A unique inhibitor conformation selectively targets the DNA polymerase PolC of Gram-positive priority pathogens

Journal:
Nature Communications
Published:
Affiliations:
6
Authors:
11
Institutions Authors Share
Acurx Pharmaceuticals, Inc. (ACXP), United States of America (USA)
5.000000
0.45
Leiden University Medical Center (LUMC), Netherlands
3.500000
0.32
Leiden University, Netherlands
1.500000
0.14
Calvin University, United States of America (USA)
1.000000
0.09